Methodist Richardson Medical Center
Richardson, Texas, 75082, United States
NCT Number: NCT06225167
Pharmacologic stress ulcer prophylaxis is routinely used in the intensive care unit (ICU) to prevent upper gastrointestinal (GI) bleeding in critically ill patients.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Richardson, Texas, 75082, United States
Historically, the two independent risk factors for stress-related GI bleeds were coagulopathy and mechanical ventilation for more than 48 hours; however, several additional risk factors have been identified, such as shock, multiple organ failure, traumatic brain injury, and major burns.
Acid suppressive medications such as proton pump inhibitors or histamine-2 receptor antagonists are prescribed to reduce the rate of bleeding from stress ulceration despite a lack of benefit from placebo-controlled trials. In addition to lack of proven benefit, the incidence of clinically significant stress-related GI bleeding has decreased over time, likely due to improvements in critical care and earlier enteral feeding.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
If patient has two or more of the following:
To evaluate the effectiveness and safety of a pharmacist-driven protocol to discontinue stress ulcer prophylaxis in ICU patients when it is no longer indicated according to pre-defined criteria.
To compare the incidence of overt GI bleeds (defined as hematemesis, bloody nasogastric tube aspirate, or melena) between patients who were on stress ulcer prophylaxis versus patients whose acid suppression therapy was discontinued through the stress ulcer prophylaxis minimization protocol.
Time frame: 24 hours
To compare the incidence of overt GI bleeds (defined as hematemesis, bloody nasogastric tube aspirate, or melena) between patients who were on stress ulcer prophylaxis versus patients whose acid suppression therapy was discontinued through the stress ulcer prophylaxis minimization protocol.
Time frame: 24 hours
To Identify the acid suppressive therapy reorder frequency
Time frame: 24 hours
Number of acid suppressive therapy doses avoided
Time frame: 24 hours
Number of HAP cases occurring
Time frame: 24 hours
Number of cases of C.Difficile infections occurring
Time frame: 24 hours
The time frame of ICU stay
Time frame: 24 hours
number of cases with ICU Delirium
Time frame: 24 hours
Different types of medications used
Time frame: 24 hours
Bleeding defined as overt GI bleeding plus one or more of the following within 24 hours such as decrease in systolic pressure, mean arterial pressure or diastolic pressure, orthostatic hypotension or postural tachycardia , drop in hemoglobin, received transfusions of packed red blood cells or need for vasopressors or invasive interventions like endoscopy.
Time frame: 24 hours
number of patients getting discharged with acid suppressive therapy
Methodist Health System
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06586333
Digestive System Diseases, Duodenal Diseases
Istanbul, Turkey, Turkey (Türkiye)
View Trial DetailsNCT02467621
Bacterial Infections, Bacterial Infections and Mycoses
Aalborg, Denmark
View Trial DetailsNCT03553563
Digestive System Diseases, Duodenal Diseases
Bunkyō City, Japan
View Trial DetailsNCT06552624
Acid-dependent Diseases of the Gastrointestinal Tract, Digestive System Diseases
Moscow, Russia
View Trial Details